3d Printed Drug
Hi zintro expert,
the zintro blog needs you! we are looking for expert opinions on the news mentioned below and would like to include your point of view. We realize your time is valuable, so here is a brief summary of what we are looking for:
*a brief answer to the prompt about 1-2 paragraphs including your full name
*participation is voluntary no payment will be involved
*if chosen, you will be named in the post and we'll include a link to your zintro profile which will generate more visitors for you
topic and prompt
this week the us food and drug administration (fda) gave the go ahead to the first 3d-printed drug, spritam, which is designed to treat seizures brought on by epilepsy in adults and children. It was developed using zipdose, a 3d printer that creates ills by printing out thin layers of medicine in powder form, with layers of a water-based binder spread between each of the powder layers. The result is a tablet that can dissolve with a sip of water in less than five seconds. Spritam will be commercially available from early 2016 onwards.
Do you think 3d-printed drugs could have the ability to transform the pharmaceuticals industry.
Getting your name and expert opinion published on our blog is a great marketing opportunity. If interested, please send a response to the prompt via znotes within 1-2 days. Don't forget to include your full name.
If you have any questions, please let us know.
Thank you!
the zintro blog team
wondering what the post would look like? Here is a sample:
http://blog.Zintro.Com/2014/08/14/rosetta-completes-10-year-trip-deep-space
/>
+3 Other ResponsesImmunosuppressive Drugs
Hi,
i am looking to understand the distribution mark-up of immunosuppressive drugs in europe by pharma companies in a marketing and distribution agreement
regards,arun
+6 Other ResponsesDrug Development
We are looking for experts in "drug development" to provide commentary and insights towards a startup developing 3d culture platform mimicking organ-specific and disease-specific human environment. we are an angel investing platform dedicated to connecting deep-tech startups with angel investors. By deep-tech we mean startups founded on scientific breakthroughs and technological innovations that create lasting impact on mankind. as a participating expert* in this process, your involvement is limited to answering anywhere between 8-12 investor-submitted questions. This takes about 1 hour (+/-) . Once you are vetted, we send those questions via a web form for your responses. If your contribution is published, it will be viewable by potential investors in this startup, giving you an opportunity to make connections, socialize virtually, and gain bragging rights in a vibrant entrepreneurial and angel investing community. *at this point, we cannot guarantee any monetary reimbursement. You do get insights to new upcoming technologies in your field and a tremendous networking opportunity!
+20 Other ResponsesGeneric Drug
We look for a consultant who is an expert in generic drug regulations, particularly for the generic drug that requires bio-ind for bio-equivalence studies; who is able to make strategic plan for the assembly of the bio-ind package and guide the communication with us fda.
+8 Other Responses
